Gene and immune-based therapies for genitourinary malignancies: current status and future prospects.
Zisman
A
A
Department of Urology, University of California, Los Angeles School of Medicine, USA. tprinz@mednet.ucla.edu
Pantuck
A J
AJ
Belldegrun
A
A
D002292:Carcinoma, Renal Cell / Q000235:genetics / Q000276:immunology / Q000628:therapy; D002295:Carcinoma, Transitional Cell / Q000235:genetics / Q000276:immunology / Q000628:therapy; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D011471:Prostatic Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy; D014565:Urogenital Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy*